SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow! -- Ignore unavailable to you. Want to Upgrade?


To: chomolungma who wrote (197)1/11/2002 7:36:38 PM
From: Saulamanca  Respond to of 258
 
No I didn`t listen to the presentation. I was surprised to see the price hold up so well today. I would have thought there would be some profit taking.

MATK got a mention in IBD today:

"Martek Biosciences broke out of a 28-week base, surging 5.66 or 25% on heavy trade. On Thursday the maker of nutritional supplements said acids it makes will be in infant formulas made by Bristol-Myers Squibb and Abbott Laboratories. The stock finished 15% above it`s pivot point of 24.72."

Good luck.